Avenue Therapeutics Market Cap

Avenue Therapeutics has a market cap or net worth of $704.23 thousand as of February 6, 2026. Its market cap has decreased by -82.33% in one year.

Market Cap

704.23K

Enterprise Value

-4.26M

Revenue

1.40M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.21

Market Cap Chart

Since June 27, 2017, Avenue Therapeutics's market cap has decreased from 27.57M to 704.23K, a decrease of -97.45%. That is a compound annual growth rate of -34.66%.

Market Cap History

Date	Market Cap	% Change
Feb 5, 2026	704.23K	-67.48%
Dec 31, 2025	2.17M	-47.28%
Dec 31, 2024	4.11M	92.60%
Dec 29, 2023	2.13M	-61.53%
Dec 30, 2022	5.54M	-70.79%
Dec 31, 2021	18.98M	-80.95%
Dec 31, 2020	Upgrade Pro	Upgrade Pro
Dec 31, 2019	Upgrade Pro	Upgrade Pro
Dec 31, 2018	Upgrade Pro	Upgrade Pro
Dec 29, 2017	Upgrade Pro	Upgrade Pro
Jun 27, 2017	Upgrade Pro	Upgrade Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
EV Biologics	839.50K
SQZ Biotechnologies Company	707.79K
Bio-Path Holdings	642.33K
Altamira Therapeutics	628.70K
Windtree Therapeutics	621.33K
Regenerative Medical Technology Group	616.22K
Regen BioPharma	556.23K
Oncology Pharma	443.42K

Market Cap Rankings